CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Regulatory T Cells but Not Tumour-Infiltrating Lymphocytes Correlate with Tumour Invasion Depth in Basal Cell Carcinoma.
Regulatory T Cells but Not Tumour-Infiltrating Lymphocytes Correlate with Tumour Invasion Depth in Basal Cell Carcinoma.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
基底细胞癌(BCC)是全球最常见的皮肤恶性肿瘤。目前证据表明,TIL(肿瘤浸润淋巴细胞)(TILs)可能影响BCC患者的临床结局。
本研究旨在分析BCC肿瘤中心(TC)、肿瘤周边(TP)和正常邻近组织(NAT)中基质TILs和调节性T细胞(Treg细胞)的浸润特征。采用免疫组织化学技术检测了43例皮肤BCC病例的111份样本中TIL(CD3+)和Treg细胞(FOXP3+/CD3+)的表达。分析了Treg细胞与TILs、浸润深度及肿瘤形态学风险的相关性。
我们发现,尽管TILs中位数相对较低(TC = 12.7%,TP = 10.3%,NAT = 3.6%),但肿瘤内Treg细胞平均比例较高(TC = 46.9%,TP = 56.1%,NAT = 51.8%),支持将BCC归类为冷肿瘤。Treg细胞比例与sTILs之间呈显著正相关(= 0.325,p < 0.001),提示TILs在Treg细胞浸润中起主要作用。Treg细胞与肿瘤浸润深度之间呈负相关(r = 0.36,p = 0.017),可能提示Treg细胞在BCC中具有抗肿瘤能力。
Basal cell carcinoma (BCC) is the most common skin malignancy worldwide. Current evidence suggests tumour-infiltrating lymphocytes (TILs) may influence the clinical outcomes of patients with BCC. The present study aimed to profile the infiltrative characteristics of stromal TILs and regulatory T cells (Treg cells) in the tumour centre (TC), tumour periphery (TP), and normal adjacent tissue (NAT) of BCC.
A total of 111 samples from 43 cutaneous BCC cases were examined for TIL (CD3+) and Treg cell (FOXP3+/CD3+) expression using immunohistochemical techniques. The correlations of Treg cells with TILs, invasion depth, and tumour morphological risk were analysed.
We identified a high mean proportion of Treg cells within the tumour (TC = 46. 9%, TP = 56. 1%, NAT = 51. 8%) despite a relatively low median of TILs (TC = 12. 7%, TP = 10. 3%, NAT = 3. 6%), supporting the classification of BCC as a cold tumour. A significant positive correlation was observed between the proportion of Treg cells and sTILs ( = 0.
325, p < 0. 001), suggesting a predominant role of TILs in the infiltration of Treg cells. An inverse correlation discovered between Treg cells and tumour invasion depth (r = 0. 36, p = 0. 017) might indicate Treg cells anti-tumour capacity in BCC.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。